about
Added value of combined gene and protein expression of CK20 and CEA in non-macroscopically involved lymph nodes of colorectal cancer.Technical limits of comparison of step-sectioning,immunohistochemistry and RT-PCR on breast cancer sentinel nodes: a study on methacarn-fixed tissue.Cytomorphologic and molecular features of hobnail variant of papillary thyroid carcinoma: case series and literature review.Flexible lab-tailored cut-offs for suitability of formalin-fixed tumor samples for diagnostic mutational analyses.Comprehensive assessment of the TCRBV repertoire in small T-cell samples by means of an improved and convenient multiplex PCR method.Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome.The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease status.Immunohistochemical and molecular profiling of histologically defined apocrine carcinomas of the breast.Effector gammadelta T cells and tumor cells as immune targets of zoledronic acid in multiple myeloma.Clonal CD8+ TCR-Vbeta expanded populations with effector memory phenotype in Churg Strauss syndrome.Severe and long-lasting disruption of T-cell receptor diversity in human myeloma after high-dose chemotherapy and autologous peripheral blood progenitor cell infusion.The molecular and functional characterization of clonally expanded CD8+ TCR BV T cells in eosinophilic granulomatosis with polyangiitis (EGPA).Long-term follow-up of idiotype vaccination in human myeloma as a maintenance therapy after high-dose chemotherapyExposure to myeloma cell lysates affects the immune competence of dendritic cells and favors the induction of Tr1-like regulatory T cells
P50
Q34901466-8C23371B-1051-45B5-B7FB-A2603F48FFA0Q35893476-1D9C5E93-8324-408A-AAFD-AB07E8BB7BD1Q38126475-4A7F6E20-2AFB-44F0-AEF5-D813ADB89DE7Q39284284-EEA7022F-B374-4A5F-A473-B74B1DC889A5Q39848077-E9AAEC5E-94D2-432A-8A93-2BF7F4118878Q40443044-9FE16A98-2117-4B59-8186-F18EDE102AB2Q41773489-4BFFF9ED-FCEA-4B42-89BC-B67F40CBDCBCQ42480186-1A77E46E-B58D-406D-B3EA-6089133BD57BQ45296414-2E00CEF4-B5E2-443C-84D4-21380A0FD61EQ51964505-024CC8E3-7C98-4FA1-B7B2-6EDBE0D65095Q52018830-53273553-A12B-493A-9B73-B36D5903456FQ53062324-91E9C363-0766-43B6-A651-245E324BE0BCQ79198818-0D7FCA17-30AE-4479-BC25-DF2AD0BCE2CCQ81510484-D6473839-83FB-4669-8B2F-CBB7529AEFB3
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Sara Mariani
@ast
Sara Mariani
@en
Sara Mariani
@es
Sara Mariani
@nl
type
label
Sara Mariani
@ast
Sara Mariani
@en
Sara Mariani
@es
Sara Mariani
@nl
prefLabel
Sara Mariani
@ast
Sara Mariani
@en
Sara Mariani
@es
Sara Mariani
@nl
P106
P1153
56730154600
P31
P496
0000-0003-3761-3612